Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders: focus on Alzheimer's disease and melatonin
Abstract: Alzheimer’s disease (AD) is associated with altered eating behavior and metabolic disruption. Amyloid plaques and neurofilament tangles are observed in many hypothalamic nuclei from AD brains. Some of these areas (suprachiasmatic nuclei, lateral hypothalamic area) also play a role in the...
Guardado en:
| Autores principales: | Spinedi, Eduardo J., Cardinali, Daniel Pedro |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Karger
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/9108 |
| Aporte de: |
Ejemplares similares
-
Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin
por: Spinedi, Eduardo Julio, et al.
Publicado: (2019) -
Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?
por: Cardinali, Daniel Pedro
Publicado: (2019) -
The polycystic ovary syndrome and the metabolic syndrome : a possible chronobiotic-cytoprotective adjuvant therapy
por: Spinedi, Eduardo J., et al.
Publicado: (2019) -
Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation
por: Brusco, Luis I., et al.
Publicado: (2022) -
Melatonin in mitochondrial dysfunction and related disorders
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)